Dietary Bromelain From Pineapple Extracts Enhanced Growth Performance and Modulated Stomach Microbiota Which Provided Longer-Term Protection to Penaeus vannamei Against Acute Hepatopancreatic Necrosis Disease (AHPND) Caused by Vibrio parahaemolyticus
{"title":"Dietary Bromelain From Pineapple Extracts Enhanced Growth Performance and Modulated Stomach Microbiota Which Provided Longer-Term Protection to Penaeus vannamei Against Acute Hepatopancreatic Necrosis Disease (AHPND) Caused by Vibrio parahaemolyticus","authors":"Wing-Keong Ng, Mei-Ling Mong","doi":"10.1155/2024/6492170","DOIUrl":null,"url":null,"abstract":"<div>\n <p>The emergence of acute hepatopancreatic necrosis disease (AHPND) caused by pathogenic strains of <i>Vibrio parahaemolyticus</i> (VP<sub>AHPND</sub>) had economically impacted shrimp farmers. There is great interest in using phytogenics as antibiotic alternatives in mitigating bacterial diseases. A 28-day feeding trial using quadruplicate groups of <i>Penaeus vannamei</i> was conducted to evaluate the efficacy of bromelain (BM), a pineapple extract, on growth, gut microbiota, and resistance to AHPND. Dietary 1% or 2% BM enhanced growth of shrimp, which was significantly (<i>P</i> < 0.05) higher at 2% BM compared to control (0% BM). In the first AHPND challenge, shrimp survival (mean ± SE) fed 1% or 2% BM were 84.8% ± 3.8% and 78.3% ± 2.5%, respectively, and significantly higher compared to the positive control group (69.6% ± 1.8%). Surviving shrimp were then regrouped into triplicates and fed the control diet for 14 days. This wash-out period was used to determine if prior dietary BM had a longer-term effect on shrimp health. In the second AHPND challenge, shrimp survival previously fed 1% or 2% BM was 71.1% ± 9.7% and 73.3% ± 3.8%, respectively, and significantly higher compared to the control group (51.1% ± 2.2%). Hepatopancreas showed less damage and harbored significantly lower <i>Vibrio</i> counts in shrimp fed BM-added diets. Dietary BM modulated the stomach bacterial community and imparted the highest alpha diversity. At the phylum level, Proteobacteria, Actinobacteria, and Bacteroidetes were the main groups across treatments but with varying relative abundance. <i>Luteolibacter</i>, <i>Paracoccus</i>, <i>Planctomyces</i>, and <i>Demequina</i> were identified as the main contributors for the diversity differences observed among treatment groups. The relative abundance of <i>Luteolibacter</i> was significantly enriched and <i>Vibrio</i> bacteria significantly lowered in the stomach of the BM-added groups. It was concluded that dietary BM induced modulation of the stomach microbiota of shrimp, which potentially enhanced its resistance to AHPND-causing VP.</p>\n </div>","PeriodicalId":8104,"journal":{"name":"Aquaculture Research","volume":"2024 1","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2024-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2024/6492170","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Aquaculture Research","FirstCategoryId":"97","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/2024/6492170","RegionNum":4,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"FISHERIES","Score":null,"Total":0}
引用次数: 0
Abstract
The emergence of acute hepatopancreatic necrosis disease (AHPND) caused by pathogenic strains of Vibrio parahaemolyticus (VPAHPND) had economically impacted shrimp farmers. There is great interest in using phytogenics as antibiotic alternatives in mitigating bacterial diseases. A 28-day feeding trial using quadruplicate groups of Penaeus vannamei was conducted to evaluate the efficacy of bromelain (BM), a pineapple extract, on growth, gut microbiota, and resistance to AHPND. Dietary 1% or 2% BM enhanced growth of shrimp, which was significantly (P < 0.05) higher at 2% BM compared to control (0% BM). In the first AHPND challenge, shrimp survival (mean ± SE) fed 1% or 2% BM were 84.8% ± 3.8% and 78.3% ± 2.5%, respectively, and significantly higher compared to the positive control group (69.6% ± 1.8%). Surviving shrimp were then regrouped into triplicates and fed the control diet for 14 days. This wash-out period was used to determine if prior dietary BM had a longer-term effect on shrimp health. In the second AHPND challenge, shrimp survival previously fed 1% or 2% BM was 71.1% ± 9.7% and 73.3% ± 3.8%, respectively, and significantly higher compared to the control group (51.1% ± 2.2%). Hepatopancreas showed less damage and harbored significantly lower Vibrio counts in shrimp fed BM-added diets. Dietary BM modulated the stomach bacterial community and imparted the highest alpha diversity. At the phylum level, Proteobacteria, Actinobacteria, and Bacteroidetes were the main groups across treatments but with varying relative abundance. Luteolibacter, Paracoccus, Planctomyces, and Demequina were identified as the main contributors for the diversity differences observed among treatment groups. The relative abundance of Luteolibacter was significantly enriched and Vibrio bacteria significantly lowered in the stomach of the BM-added groups. It was concluded that dietary BM induced modulation of the stomach microbiota of shrimp, which potentially enhanced its resistance to AHPND-causing VP.
期刊介绍:
International in perspective, Aquaculture Research is published 12 times a year and specifically addresses research and reference needs of all working and studying within the many varied areas of aquaculture. The Journal regularly publishes papers on applied or scientific research relevant to freshwater, brackish, and marine aquaculture. It covers all aquatic organisms, floristic and faunistic, related directly or indirectly to human consumption. The journal also includes review articles, short communications and technical papers. Young scientists are particularly encouraged to submit short communications based on their own research.